Objective: Immune cells are involved in the pathogenesis of osteoarthritis (OA). We examined the effects of T helper (Th) cells, which induce the expression of macrophage inflammatory protein (MIP-1g), on the progression of OA. Design: Using anterior cruciate ligament-transection (ACLT), we induced OA in one hind-leg knee joint of B6 mice. The CD4 þ T cells from splenocytes and synovium were flow-cytometrically and immunochemically evaluated, respectively. The knee joints were histologically assessed for manifestations of OA. MIP-1g levels and nuclear factor-kB (NF-kB) in the knee joints were measured using enzyme-linked immunosorbent and immunoblotting assays, respectively; osteoclastogenesis was detected by tartrateresistant acid phosphatase (TRAP) staining. The inflammatory responses and MIP-1g expression were examined using immunohistochemistry. Results: The number of CD4 þ T cells and the expression of interferon-g (IFN-g) increased during OA onset (30 days after ACLT) and then decreased at a later stage of OA (90 days after ACLT). Tissue damage induced by CD4 þ T cells was evident at the later stage. The activation of CD4 þ T cells induced the expression of MIP-1g and NF-kB. The expression of MIP-1g can be detected in synovium which CD4 þ T cells were infiltrated. The increased MIP-1g expression caused an increase in the number of osteoclasts in joints. The regulation of CD4 þ T cells was accompanied by increased macrophage infiltration and matrix metalloproteinase (MMP)-9 expression. Histopathological examinations revealed that CD4 þ T cell knockout (CD4 À/À ) mice had less expression of MIP-1g and slower cartilage degeneration than control mice had. Conclusions: CD4 þ T cells were activated during the onset of OA, but cartilage damage was more prominent at a later stage. CD4 þ T cells were involved in the pathogenesis of OA: they induced MIP-1g expression and subsequent osteoclast formation.
Introduction
Osteoarthritis (OA) is a progressive disorder of articular cartilage. Strong evidence indicates that the structural changes in OA are due to a biomechanical alteration 1 . The factors that cause OA are multiple; they include age, weight, sex, bone density, trauma history, and gene-based susceptibility 2 . Degeneration of joint cartilage, with concomitant changes in synovium and subchondral bone, is the major feature of OA. The proinflammatory mediators induced in OA synovium cause synovial hypertrophy and hyperplasia along with an increased number of lining cells and infiltrating inflammatory cells. We previously 3, 4 showed that the intraarticular injection of adenovirus-encoding genes with an antiinflammatory effect, adenoviral vector encoding kallistatin (AdHKBP) and adenoviral vector encoding thrombospondin-1 (AdTSP-1), significantly reduced the severity of OA in rat models.
Accumulating evidence suggests that T helper (Th) cells are essential in inflammatory responses and cartilage damage 5 . The immune response induced by Th cells is evident from the presence of Th cell infiltrates, the expression of Th cell activation antigens, and the expression of type 1 Th (Th1) cytokines in the synovial membranes of patients with OA. Activated Th cells stimulate monocytes to express several cytokines that contribute to the development of OA through direct cellecell contact or through soluble mediators such as interferon-g (IFN-g) and IL-17 6, 7 . Th cells contribute to the pathogenesis of bone destruction under the active control of osteoblasts and osteoclasts. Activated Th cells regulate osteoclastogenesis through the receptor activator of nuclear factor-kB ligand (RANKL) and IFN-g 8 . Osteoclast activation leads to bone resorption and subsequent destruction. Nevertheless, the mechanism of how Th cells affect osteoclastogenesis remains unclear. Fig. 1 . Quantitation of CD4 þ T cells in mice subjected to ACLT. (A) Using ACLT, OA was induced in the knee of one hind leg of mice on day 0. Splenocytes from the Sham and ACLT groups (n ¼ 4) were collected and stained for surface CD4 þ on days 30, 60, and 90. The number of CD4 þ T cells (mean AE 95% CI) is expressed as the percentage of CD4 þ T cells/1 Â 10 6 splenocytes. (B) Splenocytes of four mice per group were pooled and stained for surface CD4 and CD44 on days 30, 60, and 90. Data are expressed as the percentage of CD4 þ /CD44 þ T cells/1 Â 10 6 splenocytes. Data are representative of two independent experiments. (C) Synovial membranes from the Sham and ACLT groups on days 30, 60, 90 were removed and stained with antibody against CD4 þ (Â400 magnification). (D) Immunohistochemical staining showed higher IFN-g expression in the synovium of ACLT group mice than of Sham group mice, which showed no IFN-g expression on day 30 (Â200 magnification).
To elucidate the effect of Th cells on OA, we used cytokine array analysis in an anterior cruciate ligament-transection (ACLT) model of OA in wild-type mice and in CD4 þ T cell knockout (CD4 À/À ) mice.
Methods

Animal models
Seven-week-old male B6 and CD4 þ T cell knockout (CD4 À/À ) mice were purchased from the Laboratory Animal Center of National Cheng Kung University. The experimental protocol adhered to the rules of the Animal Protection Act of Taiwan and was approved by the university's Laboratory Animal Care and Use Committee. The mice were divided into groups that were not subjected to ACLT (Sham-group) and that were subjected to ACLT (ACLT group, CD4 þ dep/ACLT group and CD4 À/À /ACLT group). The mice in ACLT group are wild-type mice. The mice in CD4 þ dep/ACLT group are wild-type mice undergoing temporary CD4 þ T cell depletion. The mice in CD4 À/À /ACLT group are CD4 þ T cell knockout mice. To induce experimental OA, each ACLT-group mouse was anesthetized with tiletamine hydrochloride and zolazepam hydrochloride (10 mg/kg) (Zoletil 50; Virbac, Carros, France) and then subjected to a modified ACLT procedure 9 .
Flow cytometry
Splenocytes from the Sham and ACLT groups (n ¼ 4 per group) were collected on days 30, 60, and 90 after ACLT. Splenocytes (1 Â10 6 per analysis) were either single-stained with PE-conjugated-anti-CD4 (L3T4; BD Biosciences, San Jose, CA, USA) or double-stained with PE-conjugated-anti-CD4 and FITC-conjugated-anti-CD44 (Pgp-1; BD Biosciences) monoclonal antibodies for an hour at 4 C. The cells were then washed twice with staining buffer and suspended in Roswell Park Memorial Institute (RPMI)-based buffer for flow cytometric analysis.
Depleting CD4 þ T cells in mice
To produce mice with a temporary depletion of CD4 þ T cells (CD4 þ dep), we intraperitoneally injected wild-type mice (n ¼ 5) with anti-mouse CD4 (GK1.5) monoclonal antibody 7 days before ACLT. To efficiently deplete the CD4 þ T-cell population, the antibody treatment was repeated at 10-day intervals until the day before the mice were killed. CD4 þ T cell depletion (>90%) from splenocytes was confirmed using flow cytometry with anti-CD4 monoclonal antibodies (L3T4; BD Biosciences).
Immunohistochemistry and histological assessment
To analyze CD4 þ T cell infiltrates in the synovium, ACLT was used to induce OA in wild-type mice (n ¼ 4), which were then killed 30, 60, and 90 days later. Their synovial membranes were removed, fixed, and embedded in paraffin. Serial sections (5 mm thick) were cut and then incubated with rat anti-mouse CD4 (L3T4) (1:100; H129.19; BD Biosciences Pharmingen, San Diego, CA, USA) and IFN-g (1:100; Santa Cruz Biotechnology, Santa Cruz, CA, USA) antibodies at 4 C overnight. To test CD3, macrophage inflammatory protein (MIP-1g), Mac-3 antibody and matrix metalloproteinase (MMP)-9 expression, the samples from joints were prepared from wild-type and CD4 À/À mice (n ¼ 4 per group). Serial sections of cartilage were stained with hamster anti-mouse CD3 antibody (1:100) (BD Biosciences Pharmingen), rabbit anti-mouse MIP-1g antibody (1:100) (Peprotech, Rocky Hill, NJ, USA), Mac-3 (1:100) (BD Biosciences Pharmingen) and MMP-9 (1:100) (Santa Cruz Biotechnology) at 4 C overnight. After they had been sequentially incubated with the appropriate secondary antibody (1:400) (Jackson ImmunoResearch Laboratories, Inc., West Grove, PA, USA) for 2 h at room temperature with aminoethyl carbazole as the substrate chromogen (Invitrogen Zymed Laboratories, Camarillo, CA, USA), the slides were counterstained with hematoxylin and eosin.
To evaluate the effect of CD4 þ T cells at different stages of OA, ACLT was used to induce OA (n ¼ 5 per group) in wild-type mice that CD4 þ T cells had been temporary depleted (CD4 þ dep/ACLT). These mice were killed 30, 60, and 90 days later. Their synovial membranes were removed, fixed, and embedded in paraffin. Serial sections (5 mm thick) were cut and stained with hematoxylin and eosin. To test for the histopathologic changes of cartilage in CD4 þ T cell knockout mice, ACLT was used to induce OA (CD4 À/À /ACLT) (n ¼ 4 per group). On day 45 and 90, the cartilage and synovium were processed for staining with Safranin-O/fast green and hematoxylin and eosin. The histologic change in cartilage was scored using Mankin's histologic grading method 3, 10 . The histologic changes in synovial surface tissue and subsynovial tissue were evaluated and scored 3, 11 . Briefly, the grading system assigns separate scores based on two categories: (1) three subcategories of the synovial lining layer: [i] hyperplasia of the synovial lining cells (0e3 points), [ii] hypertrophy of the synovial lining layer (0e3 points), and [iii] the infiltration of inflammatory cells (0e3 points); and (2) three subcategories of the subsynovial tissue: [i] the proliferation of granulation tissue (0e3 points), [ii] vascularization (0e3 points), [iii] Fig. 2 . Evaluation of histological changes in the knee joints after the onset of ACLTinduced OA. (A) Proliferation of synovial lining cells was mildly greater in CD4 þ dep/ ACLT group mice than in Sham group mice on day 60. More severe synovitis occurred in ACLT group mice than in CD4 þ dep/ACLT mice on day 90 (Hematoxylin and eosin stain; Â200 magnification). (B) Histological examination showed a significantly higher synovitis score in the tissues from the knees of ACLT group mice on day 90. Data shown are means AE 95% CI (n ¼ 5 per group). and the infiltration of inflammatory cells (0e3 points). Total scores in each category were calculated; the maximum score was 18 points. On day 90, both groups of mice (n ¼ 6 per group) were killed and their sera collected. The tartrate-resistant acid phosphatase (TRAP) in mouse serum was assayed (MouseTRAP; Immunodiagnostic Systems, Boldon, UK). Osteoclasts in tissues were identified by histochemically staining TRAP using a commercial kit according to the manufacturer's instructions (Sigma, St Louis, MO, USA).
Assessing MIP-1g and NF-kB expression
On day 90, the mice were killed, their joints skinned, and the synovial tissue removed and dissected for homogenization in phosphate-buffered saline (PBS) containing a protease inhibitor cocktail. The homogenates from five mice in each group were pooled. MIP-1g expression in mice after ACLT was determined using a mouse inflammation antibody array kit (RayBiotech, Atlanta, GA, USA). The intensity of the signals was shown using a digital imaging analysis system (Eastman Kodak Co., Rochester, NY, USA). The relative density was normalized with an internal control and expressed as a ratio of the image density of each group divided by that of the Sham group. To quantify the MIP-1g in tissue, mouse (n ¼ 6) MIP-1g levels in the homogenates were determined using an enzymelinked immunosorbent assay (ELISA) kit (R&D Systems, Minneapolis, MN, USA). To test NF-kB activity, the homogenates were subjected to immunoblot analysis using antibodies against NF-kB p65 antibody (1:1000) (93H1; Cell Signaling, Danvers, MA, USA). b-actin expression was used as the quantitative control.
Statistical analysis
All data are represented as means plus 95% confidence intervals (CI). The quantification of CD4 þ T cells, MIP-1g and TRAP proteins in Figs. 1(A), 3(C), and 5(B) were analyzed using Student's t test.
Significance was set at P < 0.05. JMP 8.0 (SAS Institute Inc., Cary, NC, USA) was used to analyze the histological data in Figs. 2(B), 6(C) and Supplementary Fig. 2 . Significance between groups was estimated using one-way analysis of variance (ANOVA). To evaluate the differences between groups, we used Tukey's Honestly Significant Difference test set at P < 0.05.
Results
CD4 þ T cell activation during the progression of OA
To examine the alteration of CD4 þ T cells in OA, flow cytometry was used to count the number of CD4 þ T cells in splenocytes in the Sham and ACLT groups. The number of CD4 þ T cells significantly increased on day 30 in ACLT group mice compared to the Sham group mice [27.6% (25.18e30.02) vs 23.1% (18.42e27.77), P ¼ 0.017, Fig. 1(A) ], but the differences between the two groups on days 60 and 90 were not significant. CD4 þ T cell activation was further tested. On day 30, the percentage of CD4 þ /CD44 þ T cells in the ACLT group was 24.5%, higher than the 14.8% in the Sham group [ Fig. 1(B) ]. The percentages declined in both groups on day 60 (12.8% vs 17.3%), and no difference detected on day 90 (17.0% vs 17.0%). Furthermore, notable increases of CD4 þ T cells infiltrated the synovium of mice from the ACLT group on day 30. The numbers of infiltrating cells reduced on day 60 and only a few cells were detected on day 90 [ Fig. 1(C) ]. No significant change was seen in Sham group at the three time points. IFN-g was noticeably expressed in synovial tissue from ACLT knee joints on day 30 [ Fig. 1(D) ], but barely detectable on days 60 and 90 (data not shown).
In order to assess the effect of CD4 þ T cells on OA progression, CD4 þ T cells were depleted in wild-type (CD4 þ dep) mice and the histopathologic changes analyzed. Synovial membranes from three groups (Sham, CD4 þ dep/ACLT, and ACLT) showed no significant alteration during the first 2 months [ Fig. 2(A) ]. Specimens from the ACLT group mice showed hyperplasia of the lining cells and increased cell infiltration on day 90. Lesions from the CD4 þ dep/ ACLT group mice were markedly less severe. The synovitis score in the joints of ACLT group mice was significantly higher than that in CD4 þ dep/ACLT on day 90 (P < 0.001) [ Fig. 2(B) ]. These results suggest that CD4 þ T cells may induce inflammation in the early stage of OA, whereas the damage in cartilage caused by inflammation is more prominent in the later stage.
Decreased MIP-1g expression in CD4 À/À mice To identify the proteins affected by CD4 þ T cells in cartilage, we induced OA in CD4 À/À mice. Cytokine array analysis showed that several cytokines and chemokinesdsoluble tumor necrosis factor receptors II (sTNF-RII), IL-4, tissue inhibitor of metalloproteinase (TIMP)-1, and MIP-1gdwere altered in the CD4 À/À /ACLT group mice on day 90 after OA induction [ Fig. 3(A) ]. The sTNF-RII, IL-4, TIMP-1 expressions were lower, whereas MIP-1g expression was higher in the ACLT group than in the CD4 À/À /ACLT groups [ Fig. 3(B) ]. This result was confirmed using an ELISA assay. MIP-1g expression was significantly lower in the CD4 À/À /ACLT group [7673.26 (5916.08e9430.44) pg/ml] than in the ACLT group [20321.24 (17260e23382.95) pg/ml, P < 0.001] [ Fig. 3(C) ]. To detect the distribution of CD4 þ T cells and MIP-1g protein in joints, we performed the immunohistochemistry on serial sections of cartilage. No CD4 þ T cells were detected in the CD4 À/À /ACLT group mice whereas many CD4 þ T cells were infiltrated throughout the synovial membrane of the ACLT group mice (Fig. 4 ). The expression of MIP-1g was only detected in the lower metaphysic of CD4 À/À /ACLT group mice. Increased expression of MIP-1g was detected in the synovium of ACLT group mice. Very few CD4 þ T cells and MIP-1g expression were detected in the bone marrows of the Sham group mice. In the ACLT group mice, some MIP-1g expression could be detected at the same locations where CD4 þ T cells infiltrated (arrows, Fig. 4 ). Furthermore, some locations of total T cells (CD3 þ ) distribution were overlapped with those of MIP-1g expression in ACLT group mice ( Supplementary Fig. 1 ).
Decreased osteoclastogenesis in CD4 À/À mice
Because MIP-1g expression promotes osteoclast survival through NF-kB activation, we next examined the expression of activated NF-kB in mice. Ninety days after ACLT, NF-kB expression in tissue homogenate was markedly lower in CD4 À/À /ACLT group mice than in Sham and ACLT group mice [ Fig. 5(A) ]. The levels of the osteoclast marker TRAP were significantly lower in the serum of CD4 À/À /ACLT group mice (1.18 (1.055e1.305) U/L) than in that of ACLT group mice (2.59 (2.305e2.875) U/L, P < 0.001) [ Fig. 5(B) ]. Large, multinucleated osteoclasts adjacent to the calcified cartilage were prominent in ACLT group mice [ Fig. 5(C) ]. In addition, more intense staining of TRAP in the proximal tibial growth plate of ACLT group mice and its reduction in CD4 À/À /ACLT group mice was seen. These results suggested that the expression of MIP-1g and activated NF-kB upregulated osteoclast levels. Increased MIP-1g expression attracted macrophages into the synovium. Macrophage infiltration is a major feature of tissue inflammation in OA. Ninety days after ACLT, the relative number of Mac-3-positive macrophages that had infiltrated the synovium was higher in ACLT group mice than in CD4 À/À /ACLT group mice [ Fig. 5(D) ]. Given that MMP-9 is essential for recruitment of osteoclast and activated CD4 þ T cells stimulate the degradation of extracellular matrix 5,12 , we measured the expression of MMP-9 in the mice. MMP-9 expression was higher in the cartilage of ACLT mice than CD4 À/À /ACLT mice [ Fig. 5(E) ].
Evaluation of histological changes and MIP-1g expression on the cartilages of ACLT-induced OA
Histopathological examination of the knee joints of ACLT group mice revealed loss of proteoglycan on day 45 and more severe Fig. 4 . The infiltration of CD4 þ T cells and MIP-1g expression in mice with OA. Representative immunohistochemical images of the cartilage are shown (n ¼ 4 per group). (A) In the ACLT group mice, increased CD4 þ T cell infiltration and MIP-1g expression were seen in joints compared to those in the Sham and CD4 À/À /ACLT groups 90 days post-surgery (Â100 magnification, left panels). The overlapped locations of CD4 þ T cells and MIP-1g expression were indicated with arrows. The insets represent the magnified area (Â400 magnification, right panels). The CD4-positive and MIP-1gepositive cells were indicated with arrow heads. cartilage destruction with disorganized cartilage contours as well as hypocellularity was seen on day 90. However, the disease progression in CD4 À/À /ACLT group was slower. Specimens from CD4 À/À /ACLT group mice showed a mild irregularity on the surface on day 45, and decrease in cartilage thickness in the posterior of the femur on day 90 [ Fig. 6(A) ]. Most of the articular cartilage in the knee joints of Sham group mice had a smooth surface. The synovitis occurred in ACLT group mice was more severe than in CD4 À/À /ACLT group mice 90 days post-surgery ( Supplementary Fig. 2 ). The expression of MIP-1g was only detected in the lower metaphysic in Sham and CD4 À/À /ACLT groups at all time [ Fig. 6(B) ]. The staining of MIP-1g can be detected in the synovium of ACLT groups on day 45 and the MIP-1gepositive cells were evident in the chondroosseous junction on day 90. Mankin's scores of joints from ACLT group mice were significantly higher than those of joints from CD4 À/À /ACLT mice on day 90 (P ¼ 0.002) [ Fig. 6(C) ]. Taken together, these results indicated that the loss of Th cells potently alleviated inflammation and cartilage damage by inhibiting MIP-1g expression.
Discussion
To determine the potential effect of Th cells on OA development, we induced OA in the knee joints of CD4 À/À mice (CD4 À/À /ACLT). 5 . The suppression of osteoclastogenesis after ACLT in CD4 À/À mice. (A) NF-kB expression levels were higher in ACLT group mice than in CD4 À/À /ACLT group mice. (B) The serum levels of TRAP were significantly lower in CD4 À/À /ACLT mice (n ¼ 6 per group) than in ACLT group mice. (C) TRAP staining reveals that fewer osteoclasts (arrows) were formed between the cartilage and subchondral bone layer (upper panel) and tibial metaphysis (lower panel) in CD4 À/À /ACLT group mice (n ¼ 4 per group) when compared to ACLT group ones (Â400 magnification). Cart, cartilage layer; SB, subchondral bone layer. (D) The relative number of Mac-3-positive macrophages (Â200 magnification) in the subsynovial tissue of ACLT group mice was higher than that of CD4 À/À /ACLT group mice. Synovial membranes from the Sham group mice showed no significant staining. (E) Immunohistochemical staining showed higher MMP-9 expression in the cartilage from the ACLT group mice than from the CD4 À/À /ACLT group mice (Â200 magnification).
The levels of several proteinsdsTNF-RII, IL-4, TIMP-1, and MIP-1gdin the knee joints of CD4 À/À /ACLT mice were changed. The first three proteins showed a mild increase, whereas the MIP-1g showed a significant reduction. sTNF-RII and IL-4 are both believed to have anti-inflammatory functions during disease progression 13, 14 . Four members of the TIMP familydTIMP-1, -2, -3, and -4dhave been characterized 15 . TIMP-1 is a dominant cartilage TIMP that inhibits all collagenase, including MMP-1 16 . The equilibrium between The ACLT group mice showed more aggressive cartilage damage (n ¼ 4 per group). The chondrocyte loss was noted on day 45, and the disease progressed to a disappearance of the surface layer cells on day 90 (Safranin-O/fast green stain, Â200 magnification). In the CD4 À/À /ACLT group mice, the specimen showed a proteoglycan reduction and fissures in the superficial cartilaginous layer (arrow) on day 90. In the Sham group, the superficial cartilaginous layer shows a smooth and regular surface. (B) The MIP-1gepositive cells were visible in the synovium and in the chondro-osseous junction along with disease progression in ACLT group mice. The expression of MIP-1g was restricted in the lower metaphysis in the Sham and CD4 À/À /ACLT groups mice as indicated with arrows (Â400 magnification). (C) A histological examination showed lower Mankin's scores in the joints from CD4 À/À /ACLT group mice than in those from ACLT group mice. Data shown are mean AE 95% CI.
MMP-1 and TIMP-1 is controlled by Th type 2 (Th2) cytokines 17 . The absence of CD4 þ T cells may ameliorate the OA symptoms partially through the suppression of these anti-inflammatory factors. The most obvious alteration in protein level was in MIP-1g. ELISA showed an approximately 62% reduction of MIP-1g expression from the cartilage homogenate of CD4 À/À /ACLT mice when OA was induced. MIP-1g belongs to a CeC chemokine family containing MIP-1a, MIP-lb, MIP-1g, regulated upon activation, normal T cell expressed and secreted (RANTES) etc. MIP-1g is produced by monocytes and other types of leukocytes. Through binding to chemokine receptor 1 (CCR1), a specific receptor on neutrophils, MIP-1g acts as a chemoattractant that induces the chemotaxis of CD4 þ T cells, CD8 þ T cells, and monocytes 18, 19 . In the synovium of ACLT group mice, some locations of T cells infiltration and MIP-1g expression were overlapped, but others were not. It is because that T cells themselves may produce MIP-1g directly or they can stimulate other cells, such as macrophages to produce MIP-1g through RANKL signaling pathway. These infiltrating immune cells are responsible for orchestrating immune and inflammatory responses in synovium. In fact, the levels of two other members of the MIP-1 chemokine family, MIP-1a and MIP-lb, have been reported to be increased in the synovial fluid of patients with rheumatoid arthritis 20, 21 . The roles of MIP-1g in patients with arthritic diseases have not yet been clarified. MIP-1g promoted osteoclast formation and survival through the RANKL pathway 22, 23 . Bone-resorbing osteoclasts coordinately interplay with osteoblasts and remodel bone through highly regulated molecular and cellular events. The activity of the osteoclast marker TRAP was remarkably reduced in the serum of CD4 À/À /ACLT mice. In contrast, the osteoclast formation was increased in both subchondral bone and metaphyseal surfaces in the joints of ACLT group mice. The staining of MIP-1g was also more evident in the chondro-osseous junction of mice on day 90 after ACLT. The expression of MIP-1g could promote osteoclast motility 24 . Therefore, the similarly expressed locations of MIP-1g and osteoclast markers indicate that bone erosion induced by MIP-1g may occur here. Our results suggested that CD4 þ T cells regulate the activity of osteoclasts through MIP-1g protein expression during the progression of OA.
The RANKL signaling pathway derived from Th cells is responsible for pathologic osteoclastogenesis and focal erosion in arthritis 23 . However, T cells also have a negative regulatory mechanism for inhibiting osteoclastogenesis. IFN-g and IL-4 produced by the CD4 þ T cell subsets Th1 and Th2, respectively, showed an anti-osteoclastogenic effect on arthritis 25, 26 . We found IFN-g expression but no apparent cartilage damage 30 days after OA had been induced; however, 90 days after OA had been induced, we found no IFN-g expression but did find severe cartilage and bone damage. Th cell-induced IFN-g expression may compromise the activation of osteoclasts and subsequent cartilage damage in the early stage of OA. Th17 cells, a new CD4 þ T cell subset, have been identified as being primarily responsible for inducing receptor activator of nuclear factor-kB (RANK) 27 , thus causing osteoclast activation. IL-17 produced by Th17 also induced the production of MMP-9 in osteoclasts 28 . Furthermore, the secreted IL-17 induces the expression of three chemokines (monocyte chemotactic protein (MCP)-1, MIP-2, and TIMP-1), and MMP-9 in fibroblasts, and attracts both monocytes and neutrophils to the inflammatory focus 29 . Consistent with these findings, our data showed that monocyte aggregation and MMP-9 staining were more prominent 90 days after OA had been induced. Our results showed that the number of CD4 þ T cells infiltrating the synovium gradually fell during the disease progression. We suspect that in the early stage of OA, during which a large number of Th cells is activated, Th1 and Th2 cells and the cytokines they induce are important for initiating OA. During the progression of OA, some Th cells (probably Th17 cells) may continuously cause subsequent exacerbation despite a decrease in the number of Th cells. This possibility needs to be examined in additional studies. Our data suggest that temporal activation of CD4 þ T cells may affect the way in which OA manifests itself.
Our study had some limitations. First, because of the significant involvement of CD4 þ T cells in OA, in this study, their effect on the pathogenesis of OA was focused. Nevertheless, we could not rule out the potential role of CD8 þ cytotoxic T cells here, because CD3 þ T cells (the common marker of both CD4 þ and CD8 þ T cells) have been found in the angiocentric infiltrates from the synovial membrane of patients and with OA 5 . Our results also showed that CD3 þ T cells were detected in the synovium of mice with OA. In addition, CD8 þ T cells specific for common herpes viruses, such as EpsteineBarr virus and cytomegalovirus, have also been nonspecifically trapped, although in fewer patients with OA than in patients with rheumatoid arthritis, at the sites of inflammation in the synovium 30 . Whether these CD8 þ T cells recruited in synovium after viral infection are involved in OA is unclear. In a preliminary study (unpublished observations), we found that the number of CD8 þ T cells and TIMP-1 expression changed during OA progression in CD8 þ T cells knockout mice. How CD8 þ T cells affect this gene and the putative functions of the CD8 þ T cells involved in OA are under investigation. Second, we used ACLT-induced OA in our study. Based on the histological observation of animal models, we classified day 90 after ACLT treatment as the "late stage" of OA and examined the changes in cytokine expression at this time point. The actual development of OA in humans can persist for several years. Although the pathogenic characteristics of the mice in our OA animal model and in patients with OA are similar, ACLT-induced OA can not be completely translated into the clinical setting. Because cytokines fluctuate during the progression of OA, we could not rule out the possibility that other cytokines affected by CD4 þ T cells participate in the development of OA.
In conclusion, we showed that CD4 þ T cells were involved in the initiation of OA in a mouse ACLT model. Cytokine array analysis showed that MIP-1g protein expression was significantly lower in CD4 À/À /ACLT mice. MIP-1g protein may be responsible for osteoclast formation and joint destruction in the later stage of OA. We conclude that MIP-1g protein is a potential therapeutic target for the treatment of OA.
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